AI-driven drug discovery firms rallied on Friday after the U.S. Food and Drug Administration (FDA) announced an initiative to ...

The market turbulence unleashed by President Donald Trump’s tariff policies will likely evaporate the trickle of biotech IPOs ...

Oncolytics Biotech (TSX:ONC), a clinical-stage cancer therapy company, announced a US$20 million share purchase agreement ...

On The Readout LOUD podcast, STAT reporters talked with BIO's CEO John Crowley about RFK Jr. and tariffs, and discussed calls ...

For those of us who consume too much processed food in our diet, which are often low in fiber or lacking fiber entirely, ...

Experts say the layoffs are already causing issues in drug development — and things may get far worse without critical ...

Scientists have bioengineered Spirulina to produce active vitamin B12, previously found only in animal products, offering a sustainable, carbon-neutral alternative to meat and dairy. New research ...

Cellular Therapies and IDRx, crossed the $1 billion mark, a notable decrease from the six seen during the same period last ...

CellX is using an asset-light model to cost-efficiently scale production and launch a CPG brand, demonstrating the potential ...

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...